This test is most useful if any of these apply to you.
A positive result means viral genetic material from the virus behind most genital herpes was in your saliva on the day you gave the sample. That's a narrow answer. It points to oral shedding at that moment, not just a past infection. In studies of healthy adults, this virus almost never turns up in saliva.
A negative result isn't an all-clear. This is a specialized, exploratory test without standardized cutoffs for screening. It earns its place when you already have a reason to suspect oral HSV-2, and it works best paired with a blood antibody test that shows whether you've ever been infected.
HSV-2 is one of two closely related herpes simplex viruses. HSV-1 is the usual cause of cold sores, while HSV-2 mostly causes genital herpes. Both can infect either site, and both stay in your body for life once you're infected.
After the first infection, the virus can settle into nearby nerve clusters and go quiet. Scientists call this resting state latency. Where it settles depends on the site first infected. Genital HSV-2 usually lives in nerve clusters near the base of the spine; oral infection uses nerves serving the face. When the virus wakes up, it travels back along the nerve and multiplies in the skin or lining that nerve supplies.
This test uses PCR. PCR stands for polymerase chain reaction. It copies very small traces of viral genetic material until a machine can detect them. The test measures HSV-2 genetic material in saliva. What it reflects is shedding: virus or viral DNA being released from infected cells now, not a quiet infection resting in a nerve.
The first useful question is how likely this test is to find HSV-2 at all. Across the studies that looked, the answer depends heavily on who was tested.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Healthy adults with a history of cold sores, sampled repeatedly after dental work (364 saliva samples) | How often HSV-2 appeared compared with other herpes viruses | Never. Other herpes viruses, including HSV-1, showed up more often |
| 115 adults: some healthy, some with mouth-lining problems, some on immune-suppressing drugs | HSV-2 compared with Epstein-Barr virus in saliva and mouth swabs | No HSV-2 in anyone. Epstein-Barr virus led the healthy group at 61.4% |
| 30 people with untreated HIV and no symptoms | HSV-2 in saliva compared with serum | 2 of 30 (6.67%) in saliva, versus 20% in serum |
Sources: Miller et al.; Yap et al.; Sufiawati et al.
If your immune system is healthy and you have no mouth sores, a positive result would be unusual enough to take seriously, and a negative tells you very little about whether you carry HSV-2. The test is most useful when your immune system is weaker, when you already know you have HSV-2, or when a sore in your mouth or throat needs a name.
If you know you carry genital HSV-2, oral samples can still turn positive, but the best data come from oral swabs rather than saliva. In one study of 109 men with HSV-2, with and without HIV, 40.4% had at least one oral swab positive over a median of 64 days. But the day-by-day rate was low: oral HSV-2 appeared on 2.3% of sampled days, was always symptom-free, and often happened on the same days the virus was active genitally.
That short-burst pattern matters. In another study of adults with HIV who collected oral and anogenital swabs four times a day, many oral HSV shedding episodes cleared within hours. A single saliva sample can miss one by being taken on the wrong day, or even the wrong part of the day.
This matters for partners. A positive saliva result means oral contact is worth treating as a possible route of spread, especially while positive. It does not prove every exposure is infectious, because PCR finds DNA rather than live virus.
When immune control is weaker, herpes viruses surface more often. For HSV-2 specifically, the untreated HIV group in the table above had HSV-2 genetic material in saliva where healthier groups showed none. Other immune-suppressed settings show more oral shedding of herpes-family viruses, though often HSV-1 or CMV rather than HSV-2.
The link runs both ways. Carrying HSV-2 makes HIV easier to catch: a pooled analysis found roughly double the risk in higher-risk groups and nearly triple the risk in general-population cohorts. A recently caught HSV-2 infection raised it roughly fivefold. That finding is based on blood antibody status, not saliva DNA, but it's why any positive HSV-2 result should come with an HIV test.
In a small study of nine women with both infections who were on HIV treatment, genital HSV-2 shedding without symptoms went along with larger pockets of HIV hiding in tissue, the reservoirs that treatment can't clear. That study measured genital shedding, not saliva.
Most HSV-2 infections stay local. The rare exceptions explain why doctors take the virus seriously in newborns and in people with badly weakened immunity.
When herpes simplex virus reaches the bloodstream, outcomes can be severe. In one hospital series, HSV DNA was detected in blood from 29 patients. Among the 13 adults with detailed records, 6 of 10 people with weakened immune systems died. This was blood testing in hospitalized patients, not saliva testing in healthy people.
HSV-2 can also infect the membranes around the brain and spinal cord. A nationwide Danish study of 205 adults found it most often in younger women, and a meaningful share still had lingering problems when they left the hospital. Other groups studied report low death rates and fewer lasting problems, so the outlook varies.
Newborns are the other high-stakes group. Neonatal herpes, usually caught from the mother around birth, affects roughly one in 10,000 newborns worldwide, and HSV-1 now causes a growing share of those cases. If you're pregnant or planning to be, your herpes status is worth knowing well before delivery.
A few conditions have led researchers to look for herpes virus in saliva, usually without separating type 1 from type 2. Pemphigus vulgaris is a condition in which the immune system attacks the skin and mouth lining, causing blisters. In 16 people with it, finding herpes simplex DNA in saliva early in the disease went along with a harder course that resisted standard immune-suppressing treatment.
People with Behcet's disease get recurring mouth ulcers, and herpes simplex DNA has also been found in their saliva. Whether the virus drives those ulcers is still unclear. These studies looked for herpes simplex DNA, usually not HSV-2-specific DNA, so they are clues about oral herpes activity, not proof that saliva HSV-2 drives those diseases.
The test is sensitive and still misses most HSV-2 infections. That isn't a contradiction. The lab can only find virus that's in the sample, and HSV-2 is rarely in saliva at any given moment.
False positives are much less common with well-run HSV PCR than false negatives from sampling the wrong time or site. One typing assay separated HSV-1 from HSV-2 with specificity above 99.5% in clinical samples. This does not make saliva screening a settled test; it means that when viral DNA is truly present and the assay is controlled, typing is usually reliable. PCR also beats culture in lesion and mucosal samples: in one large evaluation, PCR found HSV about four times as often as culture.
One saliva sample is a snapshot of a few minutes in the life of a virus that surfaces in short bursts. That's the case for repeat testing. Each sample is another chance to catch a burst, and a pattern across several samples tells you more than any single result.
Genital research shows shedding changes over the years. It's most frequent in the first year after infection. In one study that followed people from their first outbreak, virus was found on about a third of days in that first year, well above the 10% to 20% of days typical later on, and it tapered gradually afterward without stopping completely. Whether oral shedding follows the same curve hasn't been studied as closely.
Repeat testing is most useful when timed to a question: a fresh mouth or throat sore, known HSV-2 with concern about oral shedding, weakened immunity, or checking whether daily antivirals are reducing the detectable oral signal. Routine yearly saliva testing when you're well has not been validated.
An infectious disease or sexual health specialist is the right next step for recurring outbreaks, a positive result alongside a weakened immune system, or herpes during pregnancy.
Evidence-backed interventions that affect your HSV Type 2 DNA level
HSV Type 2 DNA is best interpreted alongside these tests.
HSV Type 2 DNA is included in these pre-built panels.